Caring Brands, Inc. — fact timeline

Caring Brands, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 7, 2026, Caring Brands, Inc. (the “ Company ”) received a Staff Delisting Determination letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2.5 million in stockholders’ equity for continued listing on The Nasdaq Capital Market (the “ Stockholders’ Equity Rule ”), nor is it in compliance with either of the alternative listing standards, market value of listed securities of at least $35 milli”

Caring Brands, Inc.: Reduced quorum requirement for stockholder meetings from a majority to 33 1/3% of outstanding capital stock entitled to vote (effective 2026-03-29).

“On March 29, 2026, the Board of Directors (the “Board”) of Caring Brands, Inc. (the “Company”) approved and adopted an amendment (the “Amendment”) to the Company’s bylaws (the “Bylaws”) which reduces the number of shares required to constitute a quorum at a stockholders meeting of the holders of shares of the outstanding capital stock of the Company to provide that stockholders holding thirty-three and one-third percent (33 1/3%) of the Company’s outstanding capital stock entitled to vote at such meeting shall constitute a quorum (Section 2.06 of the Bylaws).”

Caring Brands, Inc. issued additional shares of Series A Preferred Stock of preferred stock for up to $4.0 million.

“The Purchaser shall have the right, exercisable at any time and from time to time, to purchase up to $4.0 million of additional shares of Series A Preferred Stock and Warrants from the Company (the AIR”),”

Caring Brands, Inc. issued 9,473,685 warrants to acquire up to 9,473,685 shares of Common Stock of warrant to one accredited investor for aggregate purchase price was $3,600,000.

“the Common Warrants and the conversion of the Series A Preferred Stock are both subject to beneficial ownership limitations set by the holder. The aggregate purchase price was $3,600,000. In addition, the Company will not issue any shares upon the exercise of the Warrants or the conversion of the Series A Preferred Stock to the extent that the aggregate issuances”

Caring Brands, Inc. issued 3,789,474 shares of its Series A Convertible Preferred Stock of preferred stock to one accredited investor for aggregate purchase price was $3,600,000.

“the Common Warrants and the conversion of the Series A Preferred Stock are both subject to beneficial ownership limitations set by the holder. The aggregate purchase price was $3,600,000. In addition, the Company will not issue any shares upon the exercise of the Warrants or the conversion of the Series A Preferred Stock to the extent that the aggregate issuances”

Caring Brands, Inc. entered into Securities Purchase Agreement with one accredited investor valued at $3,600,000 (effective 2026-03-19).

“On March 19, 2026, Caring Brands, Inc. (the “Company”), entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with one accredited investor (the “Purchaser”) for a private investment in public equity (the “PIPE Offering”) of 3,789,474 shares of its Series A Convertible Preferred Stock par value $0.001 per share, stated value $3,789,474 per share (the “Series A Preferred Stock”) , equating to 3,789.74 Series A Convertible Preferred Shares which equates to a purchase price of $950 per share of Series A Preferred Stock with a stated value of $1,000 per share, after factoring in an original issue discount (“OID”) of 5%.”

Caring Brands, Inc. entered into License Agreement with Itonis Pharmaceuticals (effective 2025-12-31).

“On December 31, 2025, Caring Brands, Inc., a Nevada corporation, (the “ Company ”), entered into a license agreement (the “ License Agreement ”) with Itonis Pharmaceuticals (“ Itonis ”), a Nevada corporation.”